This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Iberis amara
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
European bitter herb used historically for cardiac and respiratory conditions; now validated for dyspepsia treatment.
European bitter herb used historically for cardiac and respiratory conditions; now validated for dyspepsia treatment. Key active compounds include cucurbitacin E, kaempferol, quercetin.
cucurbitacin E, along with kaempferol and quercetin, are the primary bioactive compounds in Iberis Amara Herb. These compounds modulates NF-κB and COX-2 inflammatory pathways, stimulates digestive enzyme secretion and GI motility.
Digestive stimulant
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antispasmodic
Heart and respiratory tonic in European folk medicine
Based on traditional use; clinical evidence limited
Digestive bitter for dyspepsia
Based on traditional use; clinical evidence limited
Treatment of irritable bowel conditions
Based on traditional use; clinical evidence limited
Found an error or have a correction for Iberis Amara Herb?
Report an Issue →